The company

 GI Biopharma Inc is a company founded by Dr. Xiaofa Qin aiming at developing treatment for inflammatory bowel diseases (IBD, including ulcerative colitis and Crohn’s disease), irritable bowel syndrome (IBS) and other health problems associated dysbiosis of gut microbiota, based on Dr. Qin’s finding that impaired inactivation of digestive proteases in the lower gut due to decrease in gut bacteria in modern society may have played a critical role.